THERAPEUTICS AND TOXICOLOGY: Edited by Robert O. WrightThe institutional development award states pediatric clinical trials network: building research capacity among the rural and medically underservedSnowden, Jessicaa; Darden, Paulb; Palumbo, Paulc; Saul, Phild; Lee, Jeannettee; for the IDeA States Pediatric Clinical Trials NetworkAuthor Information aUniversity of Nebraska Medical Center, Omaha, Nebraska bUniversity of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma cDartmouth College, Hanover, New Hampshire dWest Virginia University, Morgantown, West Virginia eData Coordinating and Operations Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA Correspondence to Jeannette Lee, PhD, University of Arkansas for Medical Sciences, 824 Jack Stephens Drive, Slot 721–23, Little Rock, AR 72205, USA. Tel: +1 501 526 5837; fax: +1 501 526 6729; e-mail: firstname.lastname@example.org Current Opinion in Pediatrics: April 2018 - Volume 30 - Issue 2 - p 297-302 doi: 10.1097/MOP.0000000000000597 Buy Metrics Abstract Purpose of review The institutional development award (IDeA) program was created to increase the competitiveness of investigators in states with historically low success rates for National Institutes of Health (NIH) research funding applications. IDeA states have high numbers of rural and medically underserved residents with disproportionately high rates of infant mortality, obesity, and poverty. This program supports the development and expansion of research infrastructure and research activities in these states. The IDeA States Pediatric Clinical Trials Network (ISPCTN) is part of the environmental influences on child health outcomes program. Its purpose is to build research capacity within IDeA states and provide opportunities for children in IDeA states to participate in clinical trials. This review describes the current and future activities of the network. Recent findings In its initial year, the ISPCTN created an online series on clinical trials, initiated participation in a study conducted by the pediatric trials network, and proposed two novel clinical trials for obese children. Capacity building and clinical trial implementation will continue in future years. Summary The ISPCTN is uniquely poised to establish and support new pediatric clinical research programs in underserved populations, producing both short and long-term gains in the understanding of child health. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.